CELL THERAPEUTICS EUROPE SRL has a total of 51 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are AMER MOH SAMIR, PHARMAGENESIS INC and DAMIAN PHARMA AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 9 | |
#3 | Canada | 6 | |
#4 | China | 5 | |
#5 | Mexico | 5 | |
#6 | Italy | 4 | |
#7 | Israel | 3 | |
#8 | Republic of Korea | 3 | |
#9 | United States | 3 | |
#10 | South Africa | 3 | |
#11 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Machines | |
#5 | Measurement | |
#6 | Biotechnology | |
#7 | Macromolecular chemistry and polymers |
# | Name | Total Patents |
---|---|---|
#1 | Grugni Mario | 24 |
#2 | Colella Gennaro | 19 |
#3 | Cassin Mara | 18 |
#4 | De Munari Sergio | 16 |
#5 | Menta Ernesto | 14 |
#6 | Pardi Gianluca | 10 |
#7 | Bernareggi Alberto | 9 |
#8 | Pavesi Paolo | 9 |
#9 | Sergio De Munari | 7 |
#10 | Gennaro Colella | 6 |
Publication | Filing date | Title |
---|---|---|
EP1867657A1 | Process for the preparation of poly-a-glutamic acid and derivatives thereof | |
CN101083983A | Indole derivatives with antitumor activity | |
ZA200704914B | Use of Thiazolidinone derivatives as antiangiogenic agents | |
WO2006066775A1 | Use of diketodithiopiperazine antibiotics for the preparation of antiangiogenic pharmaceutical compositions | |
US2008038371A1 | Nanoparticle formulations of platinum compounds | |
WO2005068424A1 | Indolinone derivatives as receptor tyrosine kinase ihibitors | |
WO2004009083A1 | Antitumor compound and therapeutic uses thereof |